References
- Walker S 3d. The psychiatric presentation of Wilson's disease (hepatolenticular degeneration) with an etiologic explanation. Behav Neuropsychiatry 1969; 1(8): 38–43
- Dening TR, Berrios GE. Wilson's disease: psychiatric symptoms in 195 cases. Arch Gen Psychiatry 1989; 46(12): 1126–34
- Gilroy J, Meyer JS. Medical neurology. 3d ed. New York: Macmillan, 1979: 297–8
- Walshe JM. The physiology of copper in man and its relation to Wilson's disease. Brain 1967; 90(1): 149–76
- Williams FJ, Walshe JM. Wilson's disease: an analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents. Brain 1981; 104(4): 735–52
- Scheinberg IH, Sternlieb I, Richman J. Psychiatric manifestations in patients with Wilson's disease. Birth Defects 1968; 4(2): 85
- Dening TR, Berrios GE, Walshe JM. Wilson's disease and epilepsy. Brain 1988; 111(5): 1139–55
- Kanski JJ. Clinical ophthalmology: a systematic approach. 2d ed. Stoneham, Mass: Butterworth, 1989
- Inose T. Neuropsychiatric manifestations in Wilson's disease: attacks of disturbance of consciousness. Birth Defects 1968; 4(2): 74
- Wilson SA. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 1912; 39(Mar): 296–509
- Knehr CA, Beam AG. Psychological impairment in Wilson's disease. J Nerv Ment Dis 1956; 124(3): 251–5
- Beard AW. The association of hepatolenticular degeneration with schizophrenia. Acta Psychiatr Scand 1959; 34(1): 411–28
- Walshe JM. Penicillamine: a new oral therapy for Wilson's disease. Am J Med 1956; 21(Oct): 487–95
- Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982; 1 (Mar 20): 643–6